All In Biotech

Drug Trial Radar · NCT03100942

Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome

A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome

Last checked: Nov 20, 2026Latest source record: Oct 23, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 152 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

152

Actual

Start

May 1, 2017

Primary completion

Jan 10, 2019

Study completion Oct 2, 2019

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
Collaborators
Lakefront Biotherapeutics NV; Ono Pharmaceutical Co., Ltd.
First posted
Apr 4, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to assess the efficacy of filgotinib, lanraplenib, and tirabrutinib in adults with active Sjogren's Syndrome (SjS).

Conditions

  • Sjogren's Syndrome

Interventions

  • LanraplenibDrug

    1 x 30 mg tablet administered orally once daily

  • FilgotinibDrug

    1 x 200 mg tablet administered orally once daily

  • TirabrutinibDrug

    1 x 40 mg tablet administered orally once daily

  • Lanraplenib placeboDrug

    1 x tablet administered orally once daily

  • Filgotinib placeboDrug

    1 x tablet administered orally once daily

  • Tirabrutinib placeboDrug

    1 x tablet administered orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Fulfilling Protocol-Specified Response Criteria at Week 12, as Compared to BaselineTime frame: Week 12

Locations

53 sites in 4 countries. Site status is shown where the registry gives one.

  • AARR Arizona Arthritis & Rheumatology Research

    Mesa, Arizona

  • AARR Arizona Arthritis & Rheumatology Research

    Phoenix, Arizona

  • Medvin Clinical Research

    Covina, California

  • Inland Rheumatology Clinical Trials, Inc.

    Upland, California

  • Denver Arthritis Clinic

    Denver, Colorado

  • Clinical Research of West Florida, Inc.

    Clearwater, Florida

  • Omega Research Consultants LLC

    DeBary, Florida

  • Center for Rheumatology Immunology and Arthritis

    Fort Lauderdale, Florida

  • Suncoast Clinical Research, Inc.

    New Port Richey, Florida

  • IRIS Research and Development, LLC

    Plantation, Florida

  • North Georgia Rheumatology Group, PC

    Lawrenceville, Georgia

  • Springfield Clinic

    Springfield, Illinois

  • Center for Arthritis & Osteoporosis

    Elizabethtown, Kentucky

  • June DO, PC

    Lansing, Michigan

  • North Mississippi Medical Clinics, Inc. - Clinical Research

    Tupelo, Mississippi

  • Clayton Medical Associates

    St Louis, Missouri

  • Physician Research Collaboration, LLC

    Lincoln, Nebraska

  • Albuquerque Clinical Trials

    Albuquerque, New Mexico

  • Joint and Muscle Research Institute

    Charlotte, North Carolina

  • Cape Fear Arthritis Care, PLLC

    Leland, North Carolina

  • PMG Research of Salisbury

    Salisbury, North Carolina

  • East Penn Rheumatology Associates, P.C.

    Bethlehem, Pennsylvania

  • Altoona Center for Clinical Research

    Duncansville, Pennsylvania

  • Clinical Research Center of Reading, LLC

    Wyomissing, Pennsylvania

  • ClinSearch

    Chattanooga, Tennessee

  • Ramesh C. Gupta, MD

    Memphis, Tennessee

  • Diagnostic Group Integrated Healthcare System, Pllc

    Beaumont, Texas

  • Accurate Clinical Research Inc.

    Houston, Texas

  • Southwest Rheumatology Research

    Mesquite, Texas

  • Trinity Universal Research Associates

    Plano, Texas

  • Arthritis & Osteoporosis Clinic

    Waco, Texas

  • Wasatch Peak Family Practice

    Layton, Utah

  • The Center for Arthritis and Rheumatic Diseases, PC

    Chesapeake, Virginia

  • Arthritis Northwest

    Spokane, Washington

  • Centrum Kliniczno-Badawcze

    Elblag, Poland

  • Intermedius

    Kościan, Poland

  • Centrum Badan Klinicznych S.C

    Poznan, Poland

  • Ai Centrum Medyczne

    Poznan, Poland

  • Centrum Medyczne Amed Warszawa Targowek

    Warsaw, Poland

  • Centrum Medyczne Oporow

    Wroclaw, Poland

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.